These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28446570)

  • 21. Transmission and Antibiotic Resistance of
    Gabrielaite M; Bartell JA; Nørskov-Lauritsen N; Pressler T; Nielsen FC; Johansen HK; Marvig RL
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33472899
    [No Abstract]   [Full Text] [Related]  

  • 22. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone.
    Kanellopoulou M; Pournaras S; Iglezos H; Skarmoutsou N; Papafrangas E; Maniatis AN
    Eur J Clin Microbiol Infect Dis; 2004 Apr; 23(4):336-9. PubMed ID: 15024624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis.
    Wang M; Ridderberg W; Hansen CR; Høiby N; Jensen-Fangel S; Olesen HV; Skov M; Lemming LE; Pressler T; Johansen HK; Nørskov-Lauritsen N
    J Cyst Fibros; 2013 Dec; 12(6):638-43. PubMed ID: 23727271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation.
    Lobo LJ; Tulu Z; Aris RM; Noone PG
    Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data.
    Amoureux L; Bador J; Siebor E; Taillefumier N; Fanton A; Neuwirth C
    J Cyst Fibros; 2013 Mar; 12(2):170-6. PubMed ID: 22944724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species.
    Spilker T; Vandamme P; Lipuma JJ
    J Clin Microbiol; 2012 Sep; 50(9):3010-5. PubMed ID: 22785192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment.
    Ridderberg W; Bendstrup KE; Olesen HV; Jensen-Fangel S; Nørskov-Lauritsen N
    J Cyst Fibros; 2011 Dec; 10(6):466-9. PubMed ID: 21835703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duplex real-time PCR assay for the simultaneous detection of
    Price EP; Soler Arango V; Kidd TJ; Fraser TA; Nguyen TK; Bell SC; Sarovich DS
    Microb Genom; 2020 Jul; 6(7):. PubMed ID: 32667877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achromobacter spp. prevalence and adaptation in cystic fibrosis lung infection.
    Veschetti L; Boaretti M; Saitta GM; Passarelli Mantovani R; Lleò MM; Sandri A; Malerba G
    Microbiol Res; 2022 Oct; 263():127140. PubMed ID: 35931003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.
    Lambiase A; Catania MR; Del Pezzo M; Rossano F; Terlizzi V; Sepe A; Raia V
    Eur J Clin Microbiol Infect Dis; 2011 Aug; 30(8):973-80. PubMed ID: 21279730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and species distribution of Achromobacter sp. cultured from cystic fibrosis patients attending the Aarhus centre in Denmark.
    Gade SS; Nørskov-Lauritsen N; Ridderberg W
    J Med Microbiol; 2017 May; 66(5):686-689. PubMed ID: 28481740
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
    Krzewinski JW; Nguyen CD; Foster JM; Burns JL
    J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Draft genome sequences of four Achromobacter ruhlandii strains isolated from cystic fibrosis patients.
    Rodrigues ER; Rocha GA; Ferreira AG; Leão RS; Albano RM; Marques EA
    Mem Inst Oswaldo Cruz; 2016 Dec; 111(12):777-780. PubMed ID: 27812598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achromobacter xylosoxidans infection in an adult cystic fibrosis unit in Madrid.
    Llorca Otero L; Girón Moreno R; Buendía Moreno B; Valenzuela C; Guiu Martínez A; Alarcón Cavero T
    Enferm Infecc Microbiol Clin; 2016 Mar; 34(3):184-7. PubMed ID: 26139304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant
    Okoliegbe IN; Hijazi K; Cooper K; Ironside C; Gould IM
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816722
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.
    Dupont C; Jumas-Bilak E; Doisy C; Aujoulat F; Chiron R; Marchandin H
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30217850
    [No Abstract]   [Full Text] [Related]  

  • 37. Distribution of
    Garrigos T; Dollat M; Magallon A; Folletet A; Bador J; Abid M; Amara M; Beauruelle C; Belmonte O; Boyer P; Cardot-Martin E; Cauchie AG; Colin de Verdière S; Daurel C; Gaudru C; Hamdad F; Héry-Arnaud G; Hoellinger B; Lamoureux C; Lartigue MF; Malandain D; Marchand O; Piau C; Picot S; Revillet H; Sabouni Z; Neuwirth C; Amoureux L
    J Clin Microbiol; 2022 Jun; 60(6):e0242221. PubMed ID: 35510500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients.
    Raso T; Bianco O; Grosso B; Zucca M; Savoia D
    APMIS; 2008 Sep; 116(9):837-41. PubMed ID: 19024606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of 109 Achromobacter spp. isolates from 9 French CF centres reveals the circulation of a multiresistant clone of A. xylosoxidans belonging to ST 137.
    Amoureux L; Sauge J; Sarret B; Lhoumeau M; Bajard A; Tetu J; Bador J; Neuwirth C;
    J Cyst Fibros; 2019 Nov; 18(6):804-807. PubMed ID: 31104975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Outcomes Associated With
    Edwards BD; Somayaji R; Greysson-Wong J; Izydorczyk C; Waddell B; Storey DG; Rabin HR; Surette MG; Parkins MD
    Open Forum Infect Dis; 2020 Jan; 7(1):ofz476. PubMed ID: 31976352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.